Understanding Antipsychotics
Purpose and Use
Antipsychotics are medications primarily designed to alleviate symptoms of psychosis, including delusions, hallucinations, and paranoia, particularly in individuals with schizophrenia and bipolar disorder. These medications are a well-established treatment option for adults facing severe psychological issues. Recently, their use has expanded to include children and teenagers dealing with neurodevelopmental, behavioral, and psychiatric disorders. However, the increasing off-label prescriptions for young patients raise concerns about the safety and efficacy of these drugs in this demographic.
Concerns Regarding Off-Label Use
The rising trend of off-label antipsychotic prescriptions for youth is notable, especially given the limited alternative treatment options available. While some young individuals with attention deficit hyperactivity disorder (ADHD) or disruptive behavior disorder may benefit from these medications, it is crucial to consider the associated risks. Research indicates a correlation between the use of antipsychotics and serious side effects, including weight gain, diabetes, high cholesterol, and cardiovascular disease.
Types of Antipsychotics
Classification
Antipsychotics are classified into two main categories: first-generation (typical) and second-generation (atypical) antipsychotics. Both categories function primarily by blocking dopamine receptors in crucial brain pathways. Atypical antipsychotics also influence serotonin receptors, which play a significant role in mood regulation. The advantages of atypical antipsychotics over their first-generation counterparts remain uncertain, although some studies suggest that medications like olanzapine, risperidone, and aripiprazole might be more effective as first-line treatments for schizophrenia and bipolar disorder, albeit with increased side effects.
Evaluating Risks and Benefits in Youth
Potential Risks
The off-label use of antipsychotics among children and adolescents has been attributed to a lack of alternative treatments. However, it is essential to evaluate the potential risks. Research shows a strong association between antipsychotics and severe adverse effects, particularly concerning metabolic health.
Impact on Adiposity and Insulin Sensitivity
Antipsychotic treatment can negatively affect adiposity and insulin sensitivity. Adiposity, which refers to being overweight, is linked to a heightened risk of cardiovascular issues. Insulin sensitivity, or how the body responds to insulin, is crucial for maintaining normal blood glucose levels. Reduced insulin sensitivity can lead to various health complications, including type 2 diabetes.
Recent Research Findings
Study Overview
A randomized clinical trial conducted by researchers at Washington University School of Medicine focused on the metabolic effects of first-time antipsychotic exposure in children and adolescents. Published in JAMA Psychiatry, the study involved 144 participants aged 6 to 18 years, all diagnosed with at least one psychiatric disorder and previously untreated with antipsychotics. Participants received one of three commonly prescribed antipsychotics—aripiprazole, olanzapine, or risperidone—for 12 weeks.
Results: Changes in Body Composition
The trial revealed an increase in total body fat among all participants after 12 weeks of treatment. Notably, olanzapine resulted in the most significant fat increase (4.1%), followed by risperidone (2.3%) and aripiprazole (1.6%). Central obesity also increased, particularly with olanzapine compared to the other medications.
Insulin Sensitivity Outcomes
A decline in insulin sensitivity was observed across the combined sample by the end of the treatment period. While risperidone showed a modest improvement of 2.3%, insulin sensitivity plummeted with aripiprazole (30.2%) and olanzapine (29.3%).
Psychiatric Improvements vs. Adverse Effects
Despite these metabolic concerns, the study noted significant improvements in psychiatric symptoms among participants. However, some adverse effects were also recorded, including elevated glucose levels. Although none of the participants developed diabetes during the study, nine exhibited above-normal fasting glucose levels by the conclusion.
Comparative Adverse Effects of Olanzapine
Olanzapine treatment led to a more substantial increase in overall body fat and abdominal obesity compared to risperidone or aripiprazole. It is noteworthy that these adverse effects were observed even at low doses of the medications.
Conclusion: Weighing the Benefits Against Risks
While antipsychotics can effectively manage behavioral disorders, it is crucial to balance these benefits against their potential metabolic effects in children and adolescents. Increased body fat and diminished insulin sensitivity are linked to a higher risk of developing type 2 diabetes and cardiovascular disease later in life. The study’s strength lies in its use of direct validated quantification methods to assess adiposity and insulin sensitivity, although its short duration of 12 weeks is a limitation. Ultimately, the researchers emphasize the importance of careful consideration when prescribing antipsychotics to young patients, as the adverse metabolic effects observed may lead to significant long-term health consequences.
Reference
Ginger E. Nicol et al. Metabolic Effects of Antipsychotics on Adiposity and Insulin Sensitivity in Youths: A Randomized Clinical Trial. JAMA Psychiatry. doi:10.1001/jamapsychiatry.2018.1088